DSpace Repository

MIDKINE CAN BE EVALUATED AS A NEW OVARIAN RESERVE MARKER AT POLYCYSTIC OVARY SYNDROME CASES EXCEPT FOR UNEXPLAINED INFERTILITY CASES.

MIDKINE CAN BE EVALUATED AS A NEW OVARIAN RESERVE MARKER AT POLYCYSTIC OVARY SYNDROME CASES EXCEPT FOR UNEXPLAINED INFERTILITY CASES.

Erguven, M.; Irez, T.
URI: http://hdl.handle.net/11547/11452
Date: 2018

Show full item record

Files in this item

Thumbnail
Name: 1-s2.0-S001502821 ...
Size: 190.5Kb
Format: PDF
View/Open

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account